Skip to content

Evaluation of wrinkle improvement

Evaluation of wrinkle improvement - Evaluation of wrinkle improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050683
Enrollment
40
Registered
2023-03-27
Start date
2023-03-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

left-right comparison study Application of developed product and placebo on each half face left-right comparison study Application of developed product and placebo on each half face

Sponsors

SUNSTAR Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1)Subjects aged 60 to 79 at the time of informed consent (2)Subjects who are concerned about wrinkles (3)Subjects who consent to switch from daily skin items to specified ones (4)Subjects who spontaneously join the study with written consent after they understand and consent the objective and contents of the study

Exclusion criteria

Exclusion criteria: (1)Subjects who has factors which can influence the evaluation site (eczema and the like, trauma, acne, tumor, pigmentation, scars, etc.) (2)Subjects with a history or current history of atopic dermatitis or with a predisposition to atopic dermatitis (3)Subjects who have undergone or will undergo cosmetic treatment (Botox injections, hyaluronic acid or collagen injections, photofacials, etc.) on the evaluation area during the examination period (4)Subjects who have undergone or plan to undergo special skin care procedures (beauty salon, esthetic salon, etc.) on the evaluation site within the past 4 weeks (5)Subjects who have used medicines (e.g., steroids) as routine skin care for the evaluation site within the past 4 weeks (6)Subject who has continuously used skin care products, cosmetics, quasi-drugs, or health foods that have efficacy claims similar to or related to the efficacy studied in this study (efficacy against wrinkles and skin whitening)for the evaluated area (7)Subjects who has changed or started having health foods or using basic cosmetics or sunscreen products for the evaluated area within the past 4 weeks. (8)Subjects who have been exposed to ultraviolet radiation beyond their daily activities, such as prolonged outdoor work, exercise, swimming, leisure activities, etc., within the past 4 weeks or will be during the study period (9)Subjects who work night shifts or day/night shifts. (10)Subjects who have complications and are judged to be poorly controlled by medication or other means, or who are judged to be in need of treatment at the time of consent (11)Subjects with serious complications or pre-existing medical conditions that make them unsuitable for participation in this study (12)Subjects with a history of alcohol or drug dependence (13)Subjects who are at risk of developing allergies to cosmetics (including those who have developed skin problems, such as rashes, with cosmetics within the past year)

Design outcomes

Primary

MeasureTime frame
Evaluation of wrinkle grade 3D analysis of in vivo

Countries

Japan

Contacts

Public ContactNatsuki Yabumi

SUNSTAR Inc. R&D

natsuki.yabumi@jp.sunstar.com080-9937-4102

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026